T&R Biofab Acquires Patent Rights for Liver Organoids and Their Manufacturing Method
[Asia Economy Reporter Minji Lee] T&R Biofab announced on the 10th that it has obtained a domestic patent for liver organoids and their manufacturing method.
This patent relates to bioprinting technology capable of precisely replicating human liver tissue patterns and the liver organoids produced using this technology. It enables the rapid and precise printing of various types of cells simultaneously.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Controversy Over Mysterious Numbers at Starbucks: From Sewol Ferry and Park Geun-hye to May 18
- [Breaking] President Lee: "South Korea and Japan to Further Expand Supply Chain Cooperation"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
The company stated, "By structurally implementing the liver lobule form, organoids can be cultured for an extended period, enhancing the commercial value of the developed products and potentially being utilized to print various human tissues."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
